What’s New?

Article

Acne patients are benefitting from a robust pipeline with treatments that hold promise for increased efficacy and safety. First-in-class additions to the FDA-approved armamentarium, such as the novel antiandrogen clascoterone (Winlevi; Sun Pharma), give dermatologists and pediatricians new tools to combat this skin condition. Speakers offer insights on matching medications to individual patient needs and controlling costs.

Recent Videos
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
Tina Tan, MD
Robert Frenck, MD
Lewis Romer, MD
Susan Carnell, PhD
Lewis Romer, MD
Susan Carnell, PhD
© 2025 MJH Life Sciences

All rights reserved.